BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22399513)

  • 1. Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid.
    Gogali F; Paterakis G; Rassidakis GZ; Kaltsas G; Liakou CI; Gousis P; Neonakis E; Manoussakis MN; Liapi C
    J Clin Endocrinol Metab; 2012 May; 97(5):1474-82. PubMed ID: 22399513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
    Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
    Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
    French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
    J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
    Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
    Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
    Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
    Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases.
    Fiore E; Rago T; Scutari M; Ugolini C; Proietti A; Di Coscio G; Provenzale MA; Berti P; Grasso L; Mariotti S; Pinchera A; Vitti P
    J Endocrinol Invest; 2009 Apr; 32(4):344-51. PubMed ID: 19636204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characterization of mononuclear cells in thyroid gland and blood in Graves' disease, multinodular goiter and papillary carcinoma.
    Aanderud S; Matre R; Varhaug JE
    Int Arch Allergy Appl Immunol; 1982; 69(2):137-42. PubMed ID: 6896702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion molecules and lymphocyte recruitment in lymphocytic thyroiditis, thyroid papillary carcinoma and parotid adenolymphoma.
    Vitolo D; Palmieri MB; Marzullo A; Ruco LP; Baroni CD
    Pathol Res Pract; 1994 Nov; 190(11):999-1004. PubMed ID: 7746747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice.
    Kawai K; Resetkova E; Enomoto T; Fornasier V; Volpé R
    J Clin Endocrinol Metab; 1998 Jan; 83(1):157-64. PubMed ID: 9435434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes.
    Modi J; Patel A; Terrell R; Tuttle RM; Francis GL
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4418-25. PubMed ID: 12970319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
    Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
    Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation.
    Liu X; Liu H; Wang L; Han Y; Kong L; Zhang X
    Diagn Pathol; 2024 Feb; 19(1):29. PubMed ID: 38341587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intrathyroidal lymphocytes in autoimmune thyroid diseases].
    Aguayo J; Wohlik N; Baeza A; Carrasco AM; Pineda G
    Rev Med Chil; 1994 Jan; 122(1):19-26. PubMed ID: 8066339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
    Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
    Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Zhang J
    Front Endocrinol (Lausanne); 2020; 11():570604. PubMed ID: 33193087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.